TD Cowen Initiates Coverage On Odyssey Therapeutics with Buy Rating

Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

ODTX

0.00

TD Cowen analyst Tyler Van Buren initiates coverage on Odyssey Therapeutics (NASDAQ: ODTX) with a Buy rating.